Latanoprostene Bunod — Discount Pricing
Latanoprostene Bunod is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Latanoprostene Bunod Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $63.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Latanoprostene Bunod
Latanoprostene Bunod is a prescription medication. Ask your doctor if Latanoprostene Bunod is right for you.
How to Check Latanoprostene Bunod Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Latanoprostene Bunod at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Ophthalmology
About Latanoprostene Bunod
Latanoprostene bunod, commonly known as Vyzulta, is a groundbreaking medication used to effectively reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Managing this condition is crucial for preserving vision, and TheDrugClub is dedicated to helping our members access essential treatments like Vyzulta while maximizing their savings on prescription costs.
Latanoprostene bunod is primarily prescribed for individuals diagnosed with open-angle glaucoma or ocular hypertension. Both conditions are characterized by elevated pressure inside the eye (intraocular pressure or IOP), which can damage the optic nerve over time, leading to irreversible vision loss. By lowering IOP
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Latanoprostene Bunod is approved for (FDA label)
VYZULTA ® (latanoprostene bunod ophthalmic solution) 0.024% is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. VYZULTA is a prostaglandin analog indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 )
Source: Read the full FDA label on DailyMed. Label effective date: February 27, 2024.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Dosage forms and strengths for Latanoprostene Bunod (FDA label)
VYZULTA is a topical ophthalmic solution containing latanoprostene bunod, 0.24 mg/mL. Topical ophthalmic solution: 0.24 mg/mL latanoprostene bunod (0.024%) ( 3 )
Source: FDA prescribing information (DailyMed). Set ID: 60ce7900-a677-4fc2-88d0-1603baa9dbd4. SPL document ID: 12648511-1ae2-aaf8-e063-6394a90a2297. Label effective date: February 27, 2024. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Latanoprostene Bunod (FDA label)
The following adverse reactions are described elsewhere in the labeling: Pigmentation [see Warnings and Precautions (5.1) ] Eyelash Changes [see Warnings and Precautions (5.2) ] Intraocular Inflammation [see Warnings and Precautions (5.3) ] Macular Edema [see Warnings and Precautions (5.4) ] Bacterial Keratitis [see Warnings and Precautions (5.5) ] Use with Contact Lens [see Warnings and Precautions (5.6) ] Most common ocular adverse reactions with incidence ≥ 2% are conjunctival hyperemia (6%), eye irritation (4%), eye pain (3%), and instillation site pain (2%). ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Source: FDA prescribing information (DailyMed). Set ID: 60ce7900-a677-4fc2-88d0-1603baa9dbd4. SPL document ID: 12648511-1ae2-aaf8-e063-6394a90a2297. Label effective date: February 27, 2024. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Latanoprostene Bunod (FDA label)
None. None. ( 4 )
Source: FDA prescribing information (DailyMed). Set ID: 60ce7900-a677-4fc2-88d0-1603baa9dbd4. SPL document ID: 12648511-1ae2-aaf8-e063-6394a90a2297. Label effective date: February 27, 2024. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.